期刊文献+

联合术前MRI和术后病理评估淋巴结转移在直肠癌患者预后预测中的价值

Prognostic value of combined preoperative MRI and postoperative pathological assessment of lymph node metastasis in rectal cancer patients
下载PDF
导出
摘要 目的探究联合术前磁共振成像(MRI)和术后病理评估淋巴结转移预测直肠癌总生存期的价值。方法回顾性收集2016年1月至2021年12月2610例在中山大学附属第六医院组织病理学证实为直肠腺癌患者的临床、病理和影像学资料。所有患者均行MRI检查,并根据淋巴结术前MRI(_(MRI)N)和术后病理(_(P)N)评估的转移情况将患者分为3组:_(MRI)N+但_(P)N-(_(MRI)N+组)、P N+但_(MRI)N-(_(P)N+组)和_(MRI)N+且_(P)N+(_(MRI-P)N+组)。使用逆概率加权(IPW)校正混杂因素。采用Kaplan-Meier曲线估计总生存率,并用log-rank检验进行组间比较。使用单因素Cox回归模型分析肿瘤特征与总生存期的相关性,采用双向逐步Cox回归模型确定总生存期的独立危险因素。结果_(MRI-P)N+组比_(P)N+组、_(MRI)N+组具有更高的肿瘤分期、更频繁的神经周围侵犯、更多的远处转移和更高的死亡风险(均P<0.05)。Kaplan-Meier曲线显示_(MRI)N+组、P N+组和_(MRI-P)N+组的3年生存率分别为90.5%、79.1%和76.4%;5年生存率分别为85.7%、71.5%和59.2%。双向逐步Cox回归分析显示年龄、肿瘤位置、癌胚抗原、糖类抗原19-9、淋巴结送检个数、病理肿瘤分期、脉管内癌栓、神经周围侵犯、远处转移、新辅助治疗和辅助治疗、MRI-病理淋巴结转移是影响直肠癌患者总生存期的独立危险因素(均P<0.05)。结论联合术前MRI和术后病理评估淋巴结转移有助于更准确预测直肠癌患者的总生存期。 Objective To investigate the value of combining preoperative magnetic resonance imaging(MRI)and postoperative pathological assessment of lymph node metastasis in predicting overall survival in rectal cancer patients.Methods This retrospective study collected clinical,pathological and image information of 2610 patients histopathologically confirmed with rectal adenocarcinoma at the Sixth Affiliated Hospital of Sun Yat-sen University between January 2016 and December 2021.All patients underwent MRI scans and were divided into three groups according to lymph node status assessed by preoperative MRI(_(MRI)N)and postoperative pathology(_(P)N):_(MRI)N+but _(P)N-(_(MRI)N+group),_(P)N+but _(MRI)N-(_(P)N+group),_(MRI)N+and _(P)N+(_(MRI-P)N+group).Inverse probability weighting(IPW)was used to adjust for confounding factors.Kaplan-Meier curves were used to estimate overall survival and log-rank tests were used to compare the difference.Univariate Cox regression models were used to analyze the correlation between tumor characteristics and overall survival,and bidirectional stepwise Cox regression models were used to identify independent risk factors for overall survival.Results The _(MRI-P)N+group showed higher tumor staging,more frequent perineural invasion,more distant metastases,and a higher risk of death compared to the _(P)N+group and _(MRI)N+group(all P<0.05).Kaplan-Meier curves showed that the 3-year survival rates for the _(MRI)N+group,_(P)N+group,and _(MRI-P)N+group were 90.5%,79.1%,and 76.4%,respectively;the 5-year survival rates were 85.7%,71.5%,and 59.2%,respectively.Stepwise Cox regression showed that age,tumor location,carcinoembryonic antigen,carbohydrate antigen 19-9,lymph nodes number,pathological tumor stage,lymphovascular invasion,perineural invasion,distant metastasis,neoadjuvant therapy and adjuvant therapy,and MRI-pathology lymph node status were independent risk factors for overall survival in rectal cancer(all P<0.05).Conclusion Evaluating the lymph node status by combining preoperative MRI and postoperative pathology helps predict overall survival in rectal cancer patients more accurately.
作者 曾志明 朱攀 马德财 邸小慧 李桂婷 邹文彬 潘希敏 ZENG Zhiming;ZHU Pan;MA Decai;DI Xiaohui;LI Guiting;ZHOU Wenbin;PAN Ximin(Department of Radiology,the Sixth Affiliated Hospital,Sun Yat-Sen University,Guangzhou 510655,China;Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases,the Sixth Affiliated Hospital,Sun Yat-sen University,Guangzhou 510655,China;Biomedical Innovation Center,the Sixth Affiliated Hospital,Sun Yat-sen University,Guangzhou 510655,China)
出处 《实用医学杂志》 CAS 北大核心 2024年第11期1560-1567,共8页 The Journal of Practical Medicine
基金 国家临床重点专科项目 广东省自然科学基金项目(编号:2023A1515011292) 广东省消化系统疾病临床研究中心项目(编号:2020B1111170004)。
关键词 直肠癌 磁共振成像 淋巴结 预后 rectal cancer MRI lymph node prognosis
  • 相关文献

参考文献8

二级参考文献48

  • 1李心翔,李大卫.直肠癌新辅助放化疗临床完全缓解后处理的争议与共识[J].中国实用外科杂志,2020,40(3):325-329. 被引量:10
  • 2燕速,马新福,赵康,陈晓乾,郭灿,刘成浩.低位直肠癌常规行No.253淋巴结清扫的争议与共识[J].中国实用外科杂志,2020,40(3):315-322. 被引量:15
  • 3董新舒,赵鹏.直肠癌术后复发全盆腔脏器切除术[J].中国实用外科杂志,2004,24(7):442-443. 被引量:6
  • 4董新舒.直肠癌根治术后盆腔复发的手术治疗(附122例分析)[J].中国实用外科杂志,1995,15(12):728-729. 被引量:19
  • 5Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: The im- pact of eliminating socioeconomic and racial disparities on prema- ture cancer deaths[J]. CA CancerJ Clin, 2011, 61 (4): 212-236.
  • 6Freedman LS, Macaskill P, Smith AN. Multivariate analysis of prog- nostic factors for operable rectal cancer[J]. Lancet, 1984, 2(8405): 733-736.
  • 7Akasu T, Yamaguchi T, Fujimoto Y, et al. Abdominal sacral resection for posterior pelvic recurrence of rectal carcinoma: analyses of prog- nostic factors and recurrence patterns[J]. Ann Surg Oncol, 2007, 14(1): 74-83.
  • 8Mori T. A comparison of the new (planned) TNM classification and Japanese general rule for staging colorectal cancer[J]. Cancer Invest, 2010, 28: 387-392.
  • 9Soreide O,Norstein J.Local recurrence after operative treatment of rectal carcinoma:a strategy for change[J].J Am Coll Surg,1997, 184(11):84- 93.
  • 10Garcia AJ,Cromwell JW, Marra C, et al. Treatment of locally recurrent rectal cancer[J].Dis Colon Rectum,2001,44(12):1743- 1748.

共引文献1492

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部